Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of MI078 capsules in the treatment of postpartum depression patients (China)

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of MI078 capsules in the treatment of postpartum depression patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132204

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: Beijing An Ding Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332866

Published by HT Digital Content Services with permission from Health Daily Digest....